Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
Chia DKA, Sundar R, Kim G, Ang JJ, Lum JHY, Nga ME, Goh GH, Seet JE, Chee CE, Tan HL, Ho J, Ngoi NYL, Lee MXW, Muthu V, Chan GHJ, Pang ASL, Ang YLE, Choo JRE, Lim JSJ, Teh JL, Lwin A, Soon Y, Shabbir A, So JBY, Yong WP.
Chia DKA, et al. Among authors: lwin a.
Ann Surg Oncol. 2022 Dec;29(13):8597-8605. doi: 10.1245/s10434-022-11998-z. Epub 2022 Sep 7.
Ann Surg Oncol. 2022.
PMID: 36070113
Clinical Trial.